Institute of Organic Chemistry and Biochemistry AS CR vvi:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Institute of Organic Chemistry and Biochemistry AS CR vvi - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9410
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:チェコ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Institute of Organic Chemistry and Biochemistry AS CR vvi (IOCB) is a research institute that offers organic chemistry and biochemistry for medical and environmental applications. The institute’s scientific research includes the fields of physico-organic chemistry and biochemistry, molecular and cellular biology, computational chemistry, medicinal chemistry, and molecular pharmacology, among others. It offers its research in medical and environmental fields aims on development of new synthetic, analytical and computational procedures, biotechnological, and the development of functional molecules. IOCB also provides its research in the study of the structure, properties and biological activity of substances, nucleic acids, chemistry and biochemistry of peptides, proteins, natural materials and their components and analogues. The institute offers its services across the Czech Republic. IOCB is headquartered in Prague, the Czech Republic.

Institute of Organic Chemistry and Biochemistry AS CR vvi – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Institute of Organic Chemistry and Biochemistry AS CR vvi, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Institute of Organic Chemistry and Biochemistry AS CR vvi, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Institute of Organic Chemistry and Biochemistry AS CR vvi, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Institute of Organic Chemistry and Biochemistry AS CR vvi, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Institute of Organic Chemistry and Biochemistry AS CR vvi, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Institute of Organic Chemistry and Biochemistry AS CR vvi, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Institute of Organic Chemistry and Biochemistry Enters into Co-Development Agreement with Johns Hopkins Medicine 10
Enamine Enters Into Co-Development Agreement With MRC LMB And IOCB For Rhomboid Protease Inhibitors 11
Licensing Agreements 12
Dracen Pharma Enters into Licensing Agreement with Johns Hopkins University and Institute of Organic Chemistry 12
Institute of Organic Chemistry and Biochemistry AS CR vvi – Key Competitors 13
Institute of Organic Chemistry and Biochemistry AS CR vvi – Key Employees 14
Institute of Organic Chemistry and Biochemistry AS CR vvi – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Government and Public Interest 16
May 15, 2018: A new inhibitor of protein aggregation associated with Parkinson’s disease from Dmytro Yushchenko Group 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Institute of Organic Chemistry and Biochemistry AS CR vvi, Pharmaceuticals & Healthcare, Key Facts 2
Institute of Organic Chemistry and Biochemistry AS CR vvi, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Institute of Organic Chemistry and Biochemistry AS CR vvi, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Institute of Organic Chemistry and Biochemistry AS CR vvi, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Institute of Organic Chemistry and Biochemistry AS CR vvi, Deals By Therapy Area, 2012 to YTD 2018 8
Institute of Organic Chemistry and Biochemistry AS CR vvi, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Institute of Organic Chemistry and Biochemistry Enters into Co-Development Agreement with Johns Hopkins Medicine 10
Enamine Enters Into Co-Development Agreement With MRC LMB And IOCB For Rhomboid Protease Inhibitors 11
Dracen Pharma Enters into Licensing Agreement with Johns Hopkins University and Institute of Organic Chemistry 12
Institute of Organic Chemistry and Biochemistry AS CR vvi, Key Competitors 13
Institute of Organic Chemistry and Biochemistry AS CR vvi, Key Employees 14

List of Figures
Institute of Organic Chemistry and Biochemistry AS CR vvi, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Institute of Organic Chemistry and Biochemistry AS CR vvi, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Institute of Organic Chemistry and Biochemistry AS CR vvi, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Institute of Organic Chemistry and Biochemistry AS CR vvi, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Institute of Organic Chemistry and Biochemistry AS CR vvi, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Institute of Organic Chemistry and Biochemistry AS CR vvi, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Institute of Organic Chemistry and Biochemistry AS CR vvi, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Institute of Organic Chemistry and Biochemistry AS CR vvi, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Institute of Organic Chemistry and Biochemistry AS CR vvi:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Suven Life Sciences Ltd (SUVEN):企業の財務・戦略的SWOT分析
    Summary Suven Life Sciences Ltd (Suven), formerly Suven Pharmaceuticals Pvt Ltd designs, develops, manufactures and supplies bulk actives, drug intermediates and fine chemicals. The company offers active pharmaceutical ingredient products which include aripiprazole, calcium acetate, divalproex sodiu …
  • Lundin Gold Inc:戦略・SWOT・企業財務分析
    Lundin Gold Inc - Strategy, SWOT and Corporate Finance Report Summary Lundin Gold Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Consolidated Edison Inc (ED):電力:M&Aディール及び事業提携情報
    Summary Consolidated Edison, Inc. (Con Edison) is an investor-owned energy company that offers wide range energy related products and services through its subsidiaries. It operates regulated electricity, gas and steam businesses, and competitive energy businesses. Con Edison’s competitive energy bus …
  • PT Central Proteina Prima Tbk (CPRO):企業の財務・戦略的SWOT分析
    PT Central Proteina Prima Tbk (CPRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • EnQuest Plc (ENQ):石油・ガス:M&Aディール及び事業提携情報
    Summary EnQuest Plc (EnQuest) is an independent oil and gas exploration and production company. The company’s assets include producing oil fields, portfolio of discoveries, and new developments. Its oil and gas exploration assets are located in the UK North Sea and also have presence in oil basins o …
  • Silicon Valley Bank:企業のM&A・事業提携・投資動向
    Silicon Valley Bank - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Silicon Valley Bank Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Alliance Data Systems Corporation:企業の戦略・SWOT・財務分析
    Alliance Data Systems Corporation - Strategy, SWOT and Corporate Finance Report Summary Alliance Data Systems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Viatris Inc (VTRS):企業の財務・戦略的SWOT分析
    Viatris Inc (VTRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Aeglea BioTherapeutics Inc (AGLE)-製薬・医療分野:企業M&A・提携分析
    Summary Aeglea BioTherapeutics Inc (Aeglea BioTherapeutics), formerly Aeglea BioTherapeutics Holdings, LLC is a biotechnology company that develops and commercializes engineered human enzymes for the treatment of cancer and rare genetic diseases. The company’s product pipeline comprises AEB1102, AEB …
  • Enercon Services Inc:電力:M&Aディール及び事業提携情報
    Summary Enercon Services, Inc. (Enercon) is a diversified consulting company offering architectural engineering, environmental, technical and management services. Its offerings include licensing, operations, permitting, construction, decommissioning, and staff augmentation, cyber security and regula …
  • ATCO Power Ltd:企業の戦略的SWOT分析
    ATCO Power Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Enable Midstream Partners LP (ENBL):石油・ガス:M&Aディール及び事業提携情報
    Summary Enable Midstream Partners, LP (Enable), a subsidiary of CenterPoint Energy Inc, owns, operates, and develops natural gas and crude oil infrastructure assets. It is a limited partnership among CenterPoint Energy, OGE Energy and ArcLight Capital Partners, LLC. The company offers crude oil and …
  • Daigas Group:企業の戦略・SWOT・財務分析
    Daigas Group - Strategy, SWOT and Corporate Finance Report Summary Daigas Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • BNK Petroleum Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    BNK Petroleum Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary BNK Petroleum Inc (BNK Petroleum) is an oil and gas company. The company explores, produces and acquires large hydrocarbon reserves. The company’s project includes Tishomingo Field, Gapowo B-1 well …
  • Nexira:戦略・SWOT・企業財務分析
    Nexira - Strategy, SWOT and Corporate Finance Report Summary Nexira - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Autodesk Inc:企業のM&A・事業提携・投資動向
    Autodesk Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Autodesk Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • UBS Wealth Management:企業の戦略・SWOT・財務情報
    UBS Wealth Management - Strategy, SWOT and Corporate Finance Report Summary UBS Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • gel-e Inc-医療機器分野:企業M&A・提携分析
    Summary gel-e Inc (gel-e), formerly Remedium Technologies Inc is a medical device company that offers products for the treatment of acute wounds. The company's products include spray foams, bandages, gels, films, and band-aids. It offers proprietary technology platform that helps in development of w …
  • Armour Residential REIT, Inc.:企業のM&A・事業提携・投資動向
    Armour Residential REIT, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Armour Residential REIT, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • HDFC Standard Life Insurance Company Limited:企業の戦略・SWOT・財務情報
    HDFC Standard Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary HDFC Standard Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆